These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 29675571

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
    Chuang CP, Jong YS, Wu CY, Lo HM.
    Am J Cardiol; 2014 Mar 01; 113(5):845-50. PubMed ID: 24406111
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention.
    Jaberg L, Toggweiler S, Puck M, Frank M, Rufibach K, Lüscher TF, Corti R.
    Circ J; 2011 Mar 01; 75(11):2648-53. PubMed ID: 21891968
    [Abstract] [Full Text] [Related]

  • 26. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
    Jeong JH, Seo YH, Ahn JY, Kim KH, Seo JY, Kim MJ, Lee HT, Park PW.
    Ann Lab Med; 2016 Sep 01; 36(5):420-6. PubMed ID: 27374706
    [Abstract] [Full Text] [Related]

  • 27. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas Morales W, Bayol AP, Kriskovich JO, Medina F, Gonzalez Arjol B, Brizuela M.
    J Heart Lung Transplant; 2006 Oct 01; 25(10):1230-40. PubMed ID: 17045936
    [Abstract] [Full Text] [Related]

  • 28. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
    Dhillon OS, Narayan HK, Quinn PA, Squire IB, Davies JE, Ng LL.
    Am Heart J; 2011 Jun 01; 161(6):1163-70. PubMed ID: 21641364
    [Abstract] [Full Text] [Related]

  • 29. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
    Fu S, Xie L, Li D, Ye P, Luo L.
    Clin Interv Aging; 2015 Jun 01; 10():359-65. PubMed ID: 25670892
    [Abstract] [Full Text] [Related]

  • 30. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
    He WF, Jiang L, Chen YY, Liu YH, Chen PY, Duan CY, Zeng LH, Fan HL, Wei XB, Guo W, Chen W, Li J, Li WS, Guo ZQ, Liu ZK, Tan N, Chen JY, He PC.
    BMC Cardiovasc Disord; 2021 Apr 21; 21(1):202. PubMed ID: 33882836
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
    Núñez J, Núñez E, Bayés-Genís A, Fonarow GC, Miñana G, Bodí V, Pascual-Figal D, Santas E, Garcia-Blas S, Chorro FJ, Rizopoulos D, Sanchis J.
    Eur Heart J Acute Cardiovasc Care; 2017 Dec 21; 6(8):685-696. PubMed ID: 27199489
    [Abstract] [Full Text] [Related]

  • 34. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D, Ammirati E, Guida P, Passantino A, Raimondo R, Guida V, Sarzi Braga S, Pedretti RF, Lagioia R, Frigerio M, Catanzaro R, Oliva F.
    Int J Cardiol; 2013 Oct 03; 168(3):2120-6. PubMed ID: 23395457
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX, Zhao H.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May 03; 40(5):373-7. PubMed ID: 22883085
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.
    J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.